CX Institutional’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.57M | Buy |
94,489
+14,257
| +18% | +$1.3M | 0.25% | 97 |
|
|
2026
Q1 | $8.24M | Buy |
80,232
+52,723
| +192% | +$5.95M | 0.25% | 93 |
|
|
2025
Q4 | $3.45M | Sell |
27,509
-1,766
| -6% | -$225K | 0.1% | 162 |
|
|
2025
Q3 | $3.92M | Buy |
29,275
+4,310
| +17% | +$566K | 0.12% | 158 |
|
|
2025
Q2 | $3.4M | Sell |
24,965
-39,807
| -61% | -$5.25M | 0.12% | 160 |
|
|
2025
Q1 | $8.59M | Buy |
64,772
+50,529
| +355% | +$6.43M | 0.32% | 70 |
|
|
2024
Q4 | $1.61M | Buy |
14,243
+1,790
| +14% | +$207K | 0.06% | 194 |
|
|
2024
Q3 | $1.42M | Sell |
12,453
-428
| -3% | -$46.9K | 0.06% | 235 |
|
|
2024
Q2 | $1.34M | Buy |
12,881
+397
| +3% | +$42.1K | 0.06% | 234 |
|
|
2024
Q1 | $1.42M | Buy |
12,484
+1,920
| +18% | +$220K | 0.07% | 227 |
|
|
2023
Q4 | $1.16M | Sell |
10,564
-11,006
| -51% | -$1.1M | 0.06% | 236 |
|
|
2023
Q3 | $2.09M | Sell |
21,570
-38,551
| -64% | -$4.05M | 0.12% | 190 |
|
|
2023
Q2 | $6.55M | Buy |
60,121
+2,818
| +5% | +$300K | 0.34% | 83 |
|
|
2023
Q1 | $5.82M | Buy |
57,303
+8,445
| +17% | +$892K | 0.31% | 85 |
|
|
2022
Q4 | $5.36M | Buy |
48,858
+16,222
| +50% | +$1.68M | 0.33% | 74 |
|
|
2022
Q3 | $3.16M | Buy |
32,636
+21,894
| +204% | +$2.33M | 0.22% | 111 |
|
|
2022
Q2 | $1.17M | Sell |
10,742
-849
| -7% | -$96.4K | 0.09% | 228 |
|
|
2022
Q1 | $1.37M | Buy |
11,591
+781
| +7% | +$96.8K | 0.11% | 193 |
|
|
2021
Q4 | $1.52M | Buy |
10,810
+64
| +0.6% | +$8.19K | 0.12% | 170 |
|
|
2021
Q3 | $1.27M | Buy |
10,746
+798
| +8% | +$98K | 0.1% | 193 |
|
|
2021
Q2 | $1.15M | Buy |
9,948
+31
| +0.3% | +$3.61K | 0.09% | 196 |
|
|
2021
Q1 | $1.19M | Sell |
9,917
-70
| -0.7% | -$8.29K | 0.11% | 186 |
|
|
2020
Q4 | $1.09M | Buy |
9,987
+13
| +0.1% | +$1.41K | 0.11% | 188 |
|
|
2020
Q3 | $1.08M | Buy |
9,974
+1,135
| +13% | +$115K | 0.12% | 167 |
|
|
2020
Q2 | $808K | Sell |
8,839
-3,776
| -30% | -$341K | 0.11% | 159 |
|
|
2020
Q1 | $995K | Buy |
12,615
+3,967
| +46% | +$331K | 0.16% | 136 |
|
|
2019
Q4 | $751K | Hold |
8,648
| – | – | 0.13% | 127 |
|
|
2019
Q3 | $724K | Sell |
8,648
-129
| -1% | -$11K | 0.12% | 146 |
|
|
2019
Q2 | $738K | Buy |
8,777
+136
| +2% | +$10.7K | 0.12% | 143 |
|
|
2019
Q1 | $691K | Buy |
8,641
+540
| +7% | +$40.2K | 0.12% | 148 |
|
|
2018
Q4 | $586K | Buy |
8,101
+7,385
| +1,031% | +$519K | 0.12% | 126 |
|
|
2018
Q3 | $53K | Hold |
716
| – | – | 0.02% | 181 |
|
|
2018
Q2 | $44K | Buy |
+716
| New | +$43.4K | 0.02% | 165 |
|
Other funds holding ABT
WT
DC
CNB
PL
II
CX Institutional's ABT Position: Q2 2026 in Review
CX Institutional increased its Abbott (ABT) stake by 18% in Q2 2026, buying an estimated $1.3M and bringing the position to 94,489 shares worth $8.57M. The position accounts for 0.25% of the portfolio, ranked #97.
CX Institutional first reported a position in ABT in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.59M in Q1 2025. 673 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- CX Institutional held 94,489 shares of Abbott worth $8.57M as of Q2 2026.
- CX Institutional bought 14,257 Abbott shares in Q2 2026, an estimated $1.3M.
- Abbott made up 0.25% of CX Institutional's portfolio in Q2 2026, its #97 holding.
- CX Institutional first reported a position in Abbott in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Abbott position peaked at $8.59M in Q1 2025.
- 673 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.